Below is the table on the latest IPO GMP for Mainboard and SME IPOs, sourced from reliable market insights. This table covers current, upcoming, and recently listed IPOs. Values are unofficial and fluctuate with market sentiment. Updated daily for accuracy.
Upcoming
Ongoing
Closed
| IPO | Price | GMP (Rs.) | IPO Size (Rs.) | Open Date | Close Date | Listing Date | Status |
|---|---|---|---|---|---|---|---|
| Shreeji Global FMCG SME-IPO | 125 | -- | 80.75 | 4 Nov | 7 Nov | 12 Nov | Upcoming |
| Lenskart Solutions IPO | 402 | 87 | 7,278.02 | 31 Oct | 4 Nov | 10 Nov | Upcoming |
| Studds Accessories IPO | 585 | 55 | 455.49 | 30 Oct | 3 Nov | 7 Nov | Upcoming |
| Orkla India IPO | 730 | 87 | 1,667.54 | 29 Oct | 31 Oct | 6 Nov | Upcoming |
| Safecure SME-IPO | 102 | -- | 29.07 | 29 Oct | 31 Oct | 6 Nov | Upcoming |
| Game Changers Texfab SME-IPO Apply Now | 102 | -- | 52.08 | 28 Oct | 30 Oct | 4 Nov | Open |
| Jayesh Logistics SME-IPO Apply Now | 122 | 7 | 27.17 | 27 Oct | 29 Oct | 3 Nov | Open |
| Midwest IPO | 1,065 | 100 | 451 | 15 Oct | 17 Oct | 24 Oct | Closed |
| Canara HSBC Life IPO | 106 | 3 | 2,517.50 | 10 Oct | 14 Oct | 17 Oct | Closed |
| SK Minerals SME-IPO | 127 | 4.5 | 39.09 | 10 Oct | 14 Oct | 17 Oct | Closed |
| Sihora Industries SME-IPO | 66 | -- | 10.03 | 10 Oct | 14 Oct | 17 Oct | Closed |
| Rubicon Research IPO | 485 | 120 | 1,377.50 | 9 Oct | 13 Oct | 16 Oct | Closed |
| Canara Robeco IPO | 266 | 20 | 1,326.13 | 9 Oct | 13 Oct | 16 Oct | Closed |
| Mittal Sections SME-IPO | 143 | -- | 52.91 | 7 Oct | 9 Oct | 14 Oct | Closed |
| LG Electronics IPO | 1,140 | 460 | 11,607.01 | 7 Oct | 9 Oct | 14 Oct | Closed |
In order to predict the anticipated listing performance of both current and upcoming IPOs, investors follow the Live IPO GMP. An IPO's possibility of listing at a premium or discount to its issue price is indicated by the Grey Market Premium (GMP), an unofficial gauge of investor sentiment.
For convenience, all current and upcoming IPOs (initial public offering) are shown on this website in a single, dynamic table. Investors can make well-informed selections according to the table's important information, which includes IPO price, GMP, issue size, opening and closing dates, listing date, and current status.
IPO GMP, or Grey Market Premium, is the difference between an IPO share's issue price before to the IPO being listed on the NSE or BSE and its unofficial market price. In the grey market, which functions outside of official stock exchanges, it refers to the amount that investors are ready to pay above (or below) the issue price.
One important measure of investor sentiment and demand for a company's shares before its listing is the current IPO GMP. While a negative GMP indicates low market interest or a potential discount listing, a positive GMP indicates a strong anticipated debut and high demand.
Live IPO GMP is used as a sentiment indicator by market participants, ranging from individual traders to institutional investors. Despite being unofficial, it contributes in estimating possible listing prices and provides information about how the IPO could perform once trading starts.
Investors frequently check GMP live for a number of reasons, including:
To predict potential discounts or listing profits.
To evaluate condition and market demand prior to listing.
To compare current IPO GMP with historical IPO trends.
To decide on a subscription or exit plan with knowledge.
The GMP of IPO evolves based on:
Subscription levels during the bidding period.
market circumstances and the performance of benchmark indices.
financials, valuation, and company foundations.
Analyst estimates and recommendations from brokerage houses.
For instance, if an IPO is priced at ₹200 and trades at ₹230 in the grey market, the live GMP is ₹30, implying an estimated listing price of ₹230 (₹200 + ₹30).
Several IPOs (initial public offerings) may be active in the grey market at any given moment, each with a unique live GMP trend. To keep up with changing market sentiment, investors can track daily GMP updates across various IPOs, including mainboard, SME, and upcoming IPOs.
It's essential to remember that Grey Market Premium data is unofficial and unregulated. Due to speculative activity and market demand, prices change quickly. Investors should therefore use the current IPO GMP as supplemental information in addition to official financial data and company fundamentals, even though it offers insightful information.
The unofficial market price difference between an IPO's issue price and its anticipated listing price prior to the shares being listed on exchanges such as the NSE and BSE is known as the IPO Grey Market Premium, or IPO GMP.
Simply put, the IPO's GMP provides an indication of the anticipated listing performance by displaying the amount that grey market buyers are willing to pay above (or below) the IPO issue price.
The unofficial, uncontrolled "grey market" is where shares from initial public offerings (IPOs) are bought and traded before they are formally listed. In this market, which is not regulated by SEBI or stock exchanges, transactions are usually handled by trustworthy brokers or unofficial investor networks.
As a sentiment indicator, the GMP IPO trend shows how confident or wary investors are about the company's launch.
A positive GMP signals strong demand and expected listing gains.
A negative GMP suggests weak sentiment and potential listing discount.
Tracking the GMP of IPO helps investors:
Expect a potential listing price as well as possible profits.
Before listing, assess how the market views the business.
Examine several IPOs according to the hype generated by the market before listing.
Despite being unofficial, Grey Market Premium data is a popular statistic among retail and HNI investors since it frequently matches with subscription levels and post-listing performance..
Two additional important grey market words that are commonly used in conversations alongside IPO GMP are:
|
Term |
Meaning |
Used For |
|
IPO GMP |
Difference between IPO issue price and its expected listing price |
Measures investor sentiment |
|
Kostak Rate |
The price at which investors sell their IPO application before allotment |
Used as a hedge against allotment risk |
|
Subject to Sauda |
A conditional deal that becomes valid only if the IPO shares are allotted |
Informal contract between investors |
These terms give a complete picture of the unofficial pre-listing market activity and how investor expectations evolve before a company’s stock goes public.
The IPO GMP is a value used to predict the expected listing price of IPO and is based on the premium buyers are willing to pay on the grey market before listing on the exchange.
In other words, an IPO's GMP offers a quick assessment of the potential listing price difference between the issue price and the IPO.
The standard formula used is:
IPO GMP = (Expected Listing Price – Issue Price)
This simple calculation shows the unofficial gain or loss per share in the grey market.
Determine the Issue Price: The corporation and its book-running lead managers have determined this official price per share.
Determine the Grey Market Premium (GMP): This premium is quoted by brokers and traders in the unofficial market based on demand and investor sentiment.
Determine the expected listing price: To get an idea of what the IPO would list at on the stock exchange, add the quoted GMP to the issue price.
Calculate the Percentage of Listing Gain: To calculate the approximate listing gain in percentage terms, divide the GMP by the issue price and then multiply the result by 100.
Formula:
Listing Gain % = (GMP ÷ Issue Price) × 100
Below is a practical example demonstrating how IPO GMP is calculated in real-world terms.
|
Issue Price |
GMP (₹) |
Expected Listing Price |
Estimated Listing Gain |
|
₹150 |
₹50 |
₹200 |
₹50 (≈ 33.3%) |
Explanation:
Investors expect that an IPO that is launched at ₹150 per share and is quoting a GMP of ₹50 in the grey market would list at ₹200, which would mean a 33.3% potential listing gain.
Await possible short-term demand and listing day returns.
Assess market sentiment toward impending IPOs.
Compare multiple current IPO GMPs to identify the most promising opportunities.
Stay informed about daily fluctuations caused by changing investor mood, subscription levels, and market trends.
Live GMP data offers an early, unofficial indicator of an IPO’s expected success in the market.
Monitoring current IPO GMP values on a daily basis keeps investors informed of the most recent price changes, as they are subject to frequent fluctuations.
Although GMP IPO data provides useful directional guidance, it should be treated as speculative information, not a guaranteed profit forecast.
Investors keep an eye on more than just active IPOs; keeping watch on upcoming IPO GMP is also essential for predicting market movements and possible listing gains. This website allows customers to quickly see which IPOs (initial public offerings) are open for subscription and which have not yet begun by presenting both active and forthcoming IPOs in a single, comprehensive table.
While the GMP column offers an early assessment of investor sentiment even before to the subscription window opening, the status column in the table makes it evident whether an IPO is Upcoming or Live. These GMP valuations, despite not being official, show how investors and brokers view demand and listing possibilities.
For upcoming IPOs, the issue price and IPO size are key details for planning participation. Along with the open and close dates, investors can determine the subscription window and make timely decisions. The listing date offers a reference point for when the expected GMP could translate into actual trading performance on the exchange.
Investors can monitor current and upcoming IPOs in one location by following to the IPO GMP table. This enables them to analyze various issues, monitor changes in market sentiment, and make well-informed allocation decisions based on expected listing gains. It also aids in predicting GMP changes, which may occur every day as a result of news, market developments, or investor demand.
The IPO GMP (Grey Market Premium) is influenced by several factors which influence investor sentiment and expected listing performance. Investors can more properly evaluate GMP IPO trends and match expectations with actual market conditions by being aware of these factors.
The most important factor influencing a company's GMP for an IPO is its financial condition. Investors need to pay attention to debt ratios, return ratios, profit margins and revenue growth. Companies with strong fundamentals and consistent profitability usually attract a higher GMP, reflecting predicted listing gains, while those with weaker financials may decrease pre-listing demand.
Investor confidence and market sentiment have a big influence on IPO GMP. GMPs typically increase during bullish periods because investors expect better listing performance. On the other hand, even for IPOs that are financially stable, bearish conditions might result in lower GMP values because of a decreased willingness for risk.
GMP is impacted by the structure of subscriptions, including retail participation, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). A higher GMP is usually the result of increased demand, which is shown by oversubscription. Under-subscription may result in muted GMP, signaling limited listing upside.
Investors frequently compare recent listings for companies in the same industry to upcoming IPOs. While poor comparable listings could reduce investor excitement, strong peer success might raise expectations for the GMP IPO.
Sector-specific growth prospects, general economic patterns, and regulatory modifications can all have an effect on GMP. A flourishing IT sector or advantageous government regulations, for instance, might raise the expected listing gains, which would be reflected in a greater grey market premium.
The pre-listing grey market's supply and demand dynamics have a direct impact on GMP. While oversupply or cautious behavior might lower GMP, high investor demand for a small number of shares tends to raise it.
Investors regularly keep an eye on the GMP of IPO in order to predict its possible listing performance. Even though it offers insightful information early on, it is essential to understand its dependability before making any investment decisions.
Early Sentiment Insight: GMP provides a real-time measure of market confidence by reflecting how investors think of an IPO prior to official listing.
Short-Term Listing Gain Estimate: Investors can predict possible gains or losses on listing day by comparing GMP with the issue price.
Quick Comparison Across IPOs: It makes it possible to compare several IPOs quickly, which is helpful in determining which have higher levels of market interest.
Unofficial and Unregulated: GMP is present on the grey market, which is not regulated by stock exchange or SEBI regulation.
Speculative and Volatile: GMP is unpredictable since prices in the grey market can change significantly in response to news, rumors, and market sentiment.
May Not Reflect Actual Listing Performance: External factors and general market conditions can change results, so even a high GMP does not ensure comparable listing gains.
Always connect GMP data with company fundamentals, industry prospects, and subscription trends to optimize the usefulness of IPO GMP. GMP should be viewed as an additional tool, not a guarantee, for predicting short-term listing performance.
The differences between Kostak Rate and Subject to Sauda are explained in this section along with how they relate to the IPO GMP. It is essential to understand these terms in order to successfully navigate the pre-listing and subscription stages.
Kostak Rate is the price at which an investor can sell their IPO application before allotment. If they are not given shares, it enables investors to lower risk or lock in a tiny profit. It is a popular instrument for cautious pre-allotment trading since it takes place before the allotment result, which lowers the risk level.
Subject to Sauda is a conditional agreement that is only carried out if shares are allotted to an investor. Because the transaction is solely dependent on the allocation decision, it involves a higher risk. When allocation probabilities are obvious, seasoned investors who wish to protect possible gains typically utilize this approach.
Grey market trading of IPO shares, including the calculation and trading of IPO GMP, operates outside the official regulatory framework in India. Since these transactions are unofficial and unregulated, neither SEBI nor the stock exchanges keep an eye on or supervise them. This means that GMP values are not legally binding prices, but rather informal measures of expected listing performance.
The Securities and Exchange Board of India, or SEBI, has made it clear time and time again that transactions conducted on the grey market are not legal and outside of its jurisdiction. It is recommended that investors use care and avoid from viewing GMP data as guarantees of listing gains.
Although there have been talks about potential future regulations for grey trading, India does not yet have a clear legal framework. The grey market remains an unofficial indicator of sentiment, but it also carries the inherent risks of speculation, volatility, and disinformation.
Because grey market trading is unofficial, it is essential that investors:
Avoid making financial decisions exclusively on GMP data; instead, consider them as illustrative only.
For a more complete assessment, combine GMP insights with company fundamentals, industry prospects, and subscription patterns.
Stay informed of any SEBI recommendations or circulars that might have an impact on future grey market operations.
Disclaimer: All GMP figures are for educational purposes only and do not constitute financial advice or a legally binding value.
Investors frequently wonder how to convert IPO GMP findings into workable plans. It can be dangerous to rely only on GMP, even though it offers a glimpse of market sentiment. A more knowledgeable and successful GMP IPO approach can be made possible by combining subscription trends, fundamental analysis, and gray market data.
The use of IPO GMP becomes meaningful when paired with financial metrics such as:
EPS: A measure of profitability per share that aids in estimating possible returns.
P/E Ratio: The issue price in relation to earnings is contextualized by the P/E ratio.
Return on Equity: ROE measures how effectively a company uses the capital that its shareholders have invested in it.
Investors can determine whether a high gray market premium is consistent with the company's intrinsic value by examining GMP when combined with these fundamentals.
Monitoring retail subscription levels, Qualified Institutional Buyers (QIB), and Non-Institutional Investors (NII) provides important information. Strong demand and possible listing gains are indicated by significant oversubscription, which typically correlates with higher GMP. On the other hand, even though the GMP initially seems large, moderate subscriptions could indicate little market demand.
While rapid fluctuations could be the result of assumption or temporary hype, a steady GMP trend in the days before listing shows steady investor sentiment. Investors can better schedule their participation and establish reasonable expectations for listing performance by keeping an eye on these patterns.
Despite being a useful early indicator, GMP is not regulated and is not officially recognized. Before making financial decisions, investors should always double-check information with SEBI updates, prospectuses, and official IPO materials. Don't base all of your investment decisions just on GMP.
India's sector-specific performance trends and changing investor sentiment are reflected in the IPO GMP 2025 environment. The present IPO GMP 2025 may provide valuable insights for retail and institutional investors who wish to understand pre-listing expectations.
Grey market premiums for mainboard and SME IPOs have shown clear trends throughout 2025:
Mainboard IPOs typically have moderate to high GMP, which is indicative of both retail interest and high institutional investor engagement.
Due to smaller issue sizes and demand from specialist markets, SME IPOs exhibit more volatile GMPs.
In industries with strong development potential, GMPs have often been moving upward, indicating favorable investor sentiment and expected listing gains.
In 2025, GMPs in a few sectors have continuously increased:
Fintech & Digital Payments: Higher-than-average GMPs are the result of strong subscription levels and growth prospects.
Pharmaceuticals & Healthcare: Growing investor interest in innovation and essential services has driven consistent GMP growth.
Green technology and renewable energy: Moderate-to-high GMP trends indicate speculative optimism in investments in this nascent sector.
Investors can identify high-demand categories, compare mainboard and SME IPOs, and develop well-informed pre-listing strategies by monitoring GMP trends by sector.
Investors can align expectations and make better judgments by monitoring GMP trends in addition to the information in the above table, which provides a glimpse of pre-listing demand. The GMP insights are briefly outlined in this overview, which highlights the information's usefulness.
IPO GMP means Grey Market Premium – the unofficial premium price at which IPO shares trade before their official listing. It helps investors understand early demand before listing.
IPO GMP today shows the current unofficial premium at which IPO shares are traded in the grey market. Investors track Live IPO GMP to estimate possible listing gains.
IPO GMP is calculated as: Expected Listing Price = Issue Price + Grey Market Premium (GMP). This calculation is only indicative and depends on market demand.
IPO GMP provides an indication of investor sentiment and expected listing price. However, actual performance depends on fundamentals, market trends, and subscription.
A good GMP reflects strong investor demand and higher chances of a premium listing. It usually signals positive market sentiment before the IPO listing day.
A high GMP shows strong demand and may indicate higher listing gains. However, it does not guarantee long-term performance after the stock is listed.
A low GMP indicates weak demand and limited listing gains. Long term investors benefit from the company's strong vision and sustainability of growth.
Zero GMP means the IPO is expected to list near its issue price without any premium or discount. It signals neutral market sentiment but not always poor prospects.
Yes, IPO GMP can be negative if the grey market expects the stock to list below its issue price. This shows weak demand and possible listing day losses.
You can check Live IPO GMP today and Upcoming IPO GMP on trusted financial platforms like Finowings, which provide daily updated data for investors.
Yes, IPO GMP changes frequently depending on investor demand, market supply, and subscription levels. It is important to track updates before IPO listing.
GMP is the premium on IPO shares, Kostak Rate is the price of a full IPO application, and Subject to Sauda is the deal price if allotment is confirmed.
SME IPO GMP refers to the grey marketplace premium of Small and Medium Enterprise IPOs, which are commonly more volatile and convey higher hazard for buyers.
No, IPO GMP is completely unofficial and based on unregulated grey market trading. It is not published by SEBI or exchanges but tracked by investors.
No, gray market trading is not officially recognized or regulated by SEBI. and bears the risks for investors.
IPO GMP can be used as an indicator of demand, but it is not always reliable. Investors should check fundamentals, valuations, and subscription data too.
No, IPO GMP reflects only short-term listing demand. Long-term stock performance depends on company growth, and industry outlook beyond listing.
Upcoming IPO GMP helps investors understand pre-listing demand and market sentiment. It is useful for traders looking for short-term listing gains.
Yes, once the subscription period starts, GMP often rises or falls depending on investor response. Strong subscription usually increases the upcoming IPO GMP.
IPO GMP is fairly accurate in predicting listing prices, often 60–70%. However, sudden market changes can affect actual listing performance significantly.
Factors like subscription demand, market sentiment, sector outlook, and company financials directly affect IPO GMP today. Any change impacts listing expectations.
Yes, mainboard GMP IPOs are generally stable, but SME GMP IPOs are very volatile. Investors should consider both options separately before making an investment decision.
Generally, Listing Price ≈ Issue Price + Grey Market Premium (GMP). But the final list charge can be exchanged due to normal marketplace conditions.
Yes, grey market operators may sometimes manipulate IPO GMP for speculation. Hence, investors must use GMP with caution and consider multiple indicators.
No, investors should not apply based only on GMP. It is important to evaluate company fundamentals, financial health, valuations, and overall market conditions.